Last update 01 Nov 2024
Octapharma Gmbh
Last update 01 Nov 2024
Overview
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Non-interventional study to capture data on the use of a VWF/FVIII concentrate (wilate®) in all clinical settings of von Willebrand disease including health-related quality of life
评价人源重组第8因子在中国重度甲型血友病患者中的临床疗效、免疫原性、药代动力学和安全性的前瞻性临床研究
[Translation] A prospective clinical study to evaluate the clinical efficacy, immunogenicity, pharmacokinetics and safety of human recombinant factor VIII in Chinese patients with severe hemophilia A
Prevention of bleeding in haemophilia A by prophylactic treatment with Octanate®, Wilate®, Nuwiq®: a prospective, multi-national, non-interventional study to evaluate routine practice prophylactic treatment schedules – NIS-Previq
100 Clinical Results associated with Octapharma Gmbh
Login to view more data
Login to view more data
01 Feb 2023GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark
A snapshot analysis of a prospective, non-interventional study to evaluate real-life prophylactic treatment schedules of factor VIII concentrates
Author: Oldenburg, J ; Wenning, S ; Seeger, S ; Feddern, J ; Halimeh, S ; Behnisch, W ; Klamroth, R ; Escuriola, C
01 Feb 2019Science meets clinical practice
Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate®, Wilate® or Nuwiq® - NIS Previq”
Author: Klamroth, R. ; Seeger, S. ; Wenning, S. ; Feddern, J. ; Scholz, U. ; Huth-Kühne, A. ; Escuriola-Ettingshausen, C. ; Oldenburg, J. ; Halimeh, S.
01 Feb 2019Science meets clinical practice
Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease
Author: Kadar, J. ; Alesci, S. ; Lang, T. ; Rieke, M. ; Halimeh, S. ; Seeger, S. ; Koscielny, J. ; Feddern, J. ; von Depka, M. ; Daoud, M. ; Dempfle, C.-E.
100 Deals associated with Octapharma Gmbh
Login to view more data
100 Translational Medicine associated with Octapharma Gmbh
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 26 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free